<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35347854</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1750-2659</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Influenza and other respiratory viruses</Title><ISOAbbreviation>Influenza Other Respir Viruses</ISOAbbreviation></Journal><ArticleTitle>Associations between persistent symptoms after mild COVID-19 and long-term health status, quality of life, and psychological distress.</ArticleTitle><Pagination><StartPage>680</StartPage><EndPage>689</EndPage><MedlinePgn>680-689</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/irv.12980</ELocationID><Abstract><AbstractText Label="BACKGROUND">We sought to assess whether persistent COVID-19 symptoms beyond 6&#x2009;months (Long-COVID) among patients with mild COVID-19 is associated with poorer health status, quality of life, and psychological distress.</AbstractText><AbstractText Label="METHODS">This was a multicenter prospective cohort study that included adult outpatients with acute COVID-19 from eight sites during 2-week sampling periods from April 1 and July 28, 2020. Participants were contacted 6-11&#x2009;months after their first positive SARS-CoV-2 to complete a survey, which collected information on the severity of eight COVID-19 symptoms using a 4-point scale ranging from 0 (not present) to 3 (severe) at 1&#x2009;month before COVID-19 (pre-illness) and at follow-up; the difference for each was calculated as an attributable persistent symptom severity score. A total attributable persistent COVID-19 symptom burden score was calculated by summing the attributable persistent severity scores for all eight symptoms. Outcomes measured at long-term follow-up comprised overall health status (EuroQol visual analogue scale), quality of life (EQ-5D-5L), and psychological distress (Patient Health Questionnaire-4). The association between the total attributable persistent COVID-19 burden score and each outcome was analyzed using multivariable proportional odds regression.</AbstractText><AbstractText Label="RESULTS">Of the 2092 outpatients with COVID-19, 436 (21%) responded to the survey. The median (IQR) attributable persistent COVID-19 symptom burden score was 2 (0, 4); higher scores were associated with lower overall health status (aOR 0.63; 95% CI: 0.57-0.69), lower quality of life (aOR: 0.65; 95%CI: 0.59-0.72), and higher psychological distress (aOR: 1.40; 95%CI, 1.28-1.54) after adjusting for age, race, ethnicity, education, and income.</AbstractText><AbstractText Label="CONCLUSIONS">In participants with mild acute COVID-19, the burden of persistent symptoms was significantly associated with poorer long-term health status, poorer quality of life, and psychological distress.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. Influenza and Other Respiratory Viruses published by John Wiley &amp; Sons Ltd. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Jin H</ForeName><Initials>JH</Initials><Identifier Source="ORCID">0000-0003-0384-210X</Identifier><AffiliationInfo><Affiliation>Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Geriatric Research, Education, and Clinical Center, Tennessee Valley Healthcare System, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Womack</LastName><ForeName>Kelsey N</ForeName><Initials>KN</Initials><AffiliationInfo><Affiliation>Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tenforde</LastName><ForeName>Mark W</ForeName><Initials>MW</Initials><AffiliationInfo><Affiliation>CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Files</LastName><ForeName>D Clark</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gibbs</LastName><ForeName>Kevin W</ForeName><Initials>KW</Initials><AffiliationInfo><Affiliation>Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shapiro</LastName><ForeName>Nathan I</ForeName><Initials>NI</Initials><AffiliationInfo><Affiliation>Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prekker</LastName><ForeName>Matthew E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Hennepin County Medical Center, Minneapolis, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erickson</LastName><ForeName>Heidi L</ForeName><Initials>HL</Initials><AffiliationInfo><Affiliation>Hennepin County Medical Center, Minneapolis, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steingrub</LastName><ForeName>Jay S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Baystate Medical Center, Springfield, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qadir</LastName><ForeName>Nida</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>UCLA Medical Center, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Akram</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Oregon Health &amp; Sciences University, Portland, Oregon, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hough</LastName><ForeName>Catherine L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Oregon Health &amp; Sciences University, Portland, Oregon, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Nicholas J</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ely</LastName><ForeName>E Wesley</ForeName><Initials>EW</Initials><AffiliationInfo><Affiliation>Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Geriatric Research, Education, and Clinical Center, Tennessee Valley Healthcare System, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rice</LastName><ForeName>Todd W</ForeName><Initials>TW</Initials><AffiliationInfo><Affiliation>Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casey</LastName><ForeName>Jonathan D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lindsell</LastName><ForeName>Christopher J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gong</LastName><ForeName>Michelle N</ForeName><Initials>MN</Initials><AffiliationInfo><Affiliation>Montefiore Medical Center, The Bronx, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Srinivasan</LastName><ForeName>Vasisht</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lewis</LastName><ForeName>Nathaniel M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Manish M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Self</LastName><ForeName>Wesley H</ForeName><Initials>WH</Initials><AffiliationInfo><Affiliation>Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Influenza and Other Viruses in the Acutely Ill (IVY) Network</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 HL153584</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002369</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>75D30120C07637</GrantID><Acronym>CC</Acronym><Agency>CDC HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Influenza Other Respir Viruses</MedlineTA><NlmUniqueID>101304007</NlmUniqueID><ISSNLinking>1750-2640</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006304" MajorTopicYN="N">Health Status</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000079225" MajorTopicYN="Y">Psychological Distress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">COVID-19 outcomes</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">post-COVID conditions</Keyword><Keyword MajorTopicYN="N">post-acute sequalae of COVID-19 (PASC)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>29</Day><Hour>5</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35347854</ArticleId><ArticleId IdType="pmc">PMC9111447</ArticleId><ArticleId IdType="doi">10.1111/irv.12980</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Coronavirus COVID&#x2010;19 Global Cases by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU) 2020. https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6
</Citation></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. Post&#x2010;acute COVID&#x2010;19 syndrome. Nat Med 2021;27(4):601&#x2013;615. doi:10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue JK, Franko NM, McCulloch DJ, et al. Sequelae in Adults at 6 Months After COVID&#x2010;19 Infection. JAMA Netw Open 2021;4(2):e210830. doi:10.1001/jamanetworkopen.2021.0830</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y, et al. Post&#x2010;discharge persistent symptoms and health&#x2010;related quality of life after hospitalization for COVID&#x2010;19. J Infect. 2020;81(6):e4&#x2010;e6. doi:10.1016/j.jinf.2020.08.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A, Bernabei R, Landi F, for the Gemelli Against COVID&#x2010;19 Post&#x2010;Acute Care Study Group . Persistent Symptoms in Patients After Acute COVID&#x2010;19. Jama. 2020;324(6):603&#x2013;605. doi:10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6&#x2010;month consequences of COVID&#x2010;19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232. doi:10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez&#x2010;Leon S, Wegman&#x2010;Ostrosky T, Perelman C, et al. More than 50 long&#x2010;term effects of COVID&#x2010;19: a systematic review and meta&#x2010;analysis. Sci Rep. 2021;11(1):16144. doi:10.1038/s41598-021-95565-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D, Baumeister RF, Veilleux JC, et al. Risk factors associated with mental illness in hospital discharged patients infected with COVID&#x2010;19 in Wuhan, China. Psychiatry Res. 2020;292:113297. doi:10.1016/j.psychres.2020.113297</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2020.113297</ArticleId><ArticleId IdType="pmc">PMC7355324</ArticleId><ArticleId IdType="pubmed">32707218</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Patel MM, Ginde AA, et al. Effectiveness of SARS&#x2010;CoV&#x2010;2 mRNA Vaccines for Preventing Covid&#x2010;19 Hospitalizations in the United States. Clin Infect Dis. 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Self WH, Adams K, et al. Influenza and Other Viruses in the Acutely Ill (IVY) Network Association Between mRNA Vaccination and COVID&#x2010;19 Hospitalization and Disease Severity. Jama. 2021;326(20):2043&#x2013;2054. doi:10.1001/jama.2021.19499</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.19499</ArticleId><ArticleId IdType="pmc">PMC8569602</ArticleId><ArticleId IdType="pubmed">34734975</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher KA, Olson SM, Tenforde MW, et al. Telework before illness onset among symptomatic adults aged &gt;/=18 years with and without COVID&#x2010;19 in 11 outpatient health care facilities&#x2014;United States, July 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1648&#x2013;1653.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7643895</ArticleId><ArticleId IdType="pubmed">33151918</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher KA, Tenforde MW, Feldstein LR, et al. Community and close contact exposures associated with COVID&#x2010;19 among symptomatic adults &gt;/=18 years in 11 outpatient health care facilities&#x2014;United States, July 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1258&#x2013;1264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7499837</ArticleId><ArticleId IdType="pubmed">32915165</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID&#x2010;19 in a multistate health care systems network&#x2014;United States, March&#x2013;June 2020 MMWR Morb Mortal Wkly Rep. 2020;69(30):993&#x2013;998. doi:10.15585/mmwr.mm6930e1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabin R, De Charro F. EQ&#x2010;5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33(5):337&#x2013;343. doi:10.3109/07853890109002087</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/07853890109002087</ArticleId><ArticleId IdType="pubmed">11491192</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P, Lin KC, Liing RJ, Wu CY, Chen CL, Chang KC. Validity, responsiveness, and minimal clinically important difference of EQ&#x2010;5D&#x2010;5L in stroke patients undergoing rehabilitation. Qual Life Res. 2016;25(6):1585&#x2013;1596. doi:10.1007/s11136-015-1196-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-015-1196-z</ArticleId><ArticleId IdType="pubmed">26714699</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanini A, Aiello M, Adamo D, et al. Estimation of minimal clinically important difference in EQ&#x2010;5D visual analog scale score after pulmonary rehabilitation in subjects with COPD. Respir Care. 2015;60(1):88&#x2013;95. doi:10.4187/respcare.03272</Citation><ArticleIdList><ArticleId IdType="doi">10.4187/respcare.03272</ArticleId><ArticleId IdType="pubmed">25336531</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson JA, Coons SJ, Ergo A, Szava&#x2010;Kovats G. Valuation of EuroQOL (EQ&#x2010;5D) health states in an adult US sample. Pharmacoeconomics. 1998;13(4):421&#x2013;433. doi:10.2165/00019053-199813040-00005</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00019053-199813040-00005</ArticleId><ArticleId IdType="pubmed">10178666</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickard AS, Law EH, Jiang R, et al. United States Valuation of EQ&#x2010;5D&#x2010;5L Health States Using an International Protocol. Value Health. 2019;22(8):931&#x2013;941. doi:10.1016/j.jval.2019.02.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2019.02.009</ArticleId><ArticleId IdType="pubmed">31426935</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JB, Lowe B. An ultra&#x2010;brief screening scale for anxiety and depression: the PHQ&#x2010;4. Psychosomatics 2009;50(6):613&#x2013;621. doi:10.1176/appi.psy.50.6.613</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.psy.50.6.613</ArticleId><ArticleId IdType="pubmed">19996233</ArticleId></ArticleIdList></Reference><Reference><Citation>Havervall S, Rosell A, Phillipson M, et al. Symptoms and Functional Impairment Assessed 8 Months After Mild COVID&#x2010;19 Among Health Care Workers. Jama. 2021;325(19):2015&#x2013;2016. doi:10.1001/jama.2021.5612</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.5612</ArticleId><ArticleId IdType="pmc">PMC8027932</ArticleId><ArticleId IdType="pubmed">33825846</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham EL, Clark JR, Orban ZS, et al. Persistent neurologic symptoms and cognitive dysfunction in non&#x2010;hospitalized Covid&#x2010;19 "long haulers". Ann Clin Transl Neurol. 2021;8(5):1073&#x2013;1085. doi:10.1002/acn3.51350</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M, Braillard O, Chappuis F, Courvoisier DS, Guessous I, CoviCare Study T. Prevalence of symptoms more than seven months after diagnosis of symptomatic COVID&#x2010;19 in an outpatient setting. Ann Intern Med. 2021;174(9):1252&#x2013;1260. doi:10.7326/M21-0878</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M21-0878</ArticleId><ArticleId IdType="pmc">PMC8280535</ArticleId><ArticleId IdType="pubmed">34224254</ArticleId></ArticleIdList></Reference><Reference><Citation>
Belluck P.
&#x2018;I Feel Like I Have Dementia&#x2019;: brain fog plagues covid survivors. 2020. Accessed March 10, 2021. https://www.nytimes.com/2020/10/11/health/covid-survivors.html
</Citation></Reference><Reference><Citation>Hellmuth J, Barnett TA, Asken BM, et al. Persistent COVID&#x2010;19&#x2010;associated neurocognitive symptoms in non&#x2010;hospitalized patients. J Neurovirol. 2021;27(1):191&#x2013;195. doi:10.1007/s13365-021-00954-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-021-00954-4</ArticleId><ArticleId IdType="pmc">PMC7852463</ArticleId><ArticleId IdType="pubmed">33528824</ArticleId></ArticleIdList></Reference><Reference><Citation>Lutchmansingh DD, Knauert MP, Antin&#x2010;Ozerkis DE, et al. A clinic blueprint for post&#x2010;coronavirus disease 2019 recovery: learning from the past, looking to the future. Chest. 2021;159(3):949&#x2013;958. doi:10.1016/j.chest.2020.10.067</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2020.10.067</ArticleId><ArticleId IdType="pmc">PMC7641526</ArticleId><ArticleId IdType="pubmed">33159907</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Brien H, Tracey MJ, Ottewill C, et al. An integrated multidisciplinary model of COVID&#x2010;19 recovery care. Ir J Med Sci. 2021;190(2):461&#x2013;468. doi:10.1007/s11845-020-02354-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11845-020-02354-9</ArticleId><ArticleId IdType="pmc">PMC7475726</ArticleId><ArticleId IdType="pubmed">32894436</ArticleId></ArticleIdList></Reference><Reference><Citation>
CDC
. Evaluating and caring for patients with post&#x2010;COVID conditions: interim guidance. January 22, 2022. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-index.html
</Citation></Reference><Reference><Citation>Pedersen MJ, Nielsen CV. Improving survey response rates in online panels: effects of low&#x2010;cost incentives and cost&#x2010;free text appeal interventions. Soc Sci Comput Rev. 2014;34:229&#x2010;243.</Citation></Reference><Reference><Citation>
Pew Research Center
. Mobile fact sheet. 2021 April 17; 2021. January 16, 2022. https://www.pewresearch.org/internet/fact-sheet/mobile/
</Citation></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6&#x2010;month neurological and psychiatric outcomes in 236 379 survivors of COVID&#x2010;19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(5):416&#x2013;427. doi:10.1016/S2215-0366(21)00084-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>